Vaccine Development Insights

The discussion highlights the unprecedented speed of vaccine development, particularly for Johnson & Johnson. Following the release of the virus's genetic sequence, the team swiftly designed candidate vaccine antigens within just three days—an extraordinary pace not typical in vaccine research. The urgency of the pandemic underscored the need for a vaccine, leading to a remarkable acceleration in the process.